US Dollar vs MXN

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

CADX

(MM) (CADX)

(MM)

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CADX

1 2 3 4 5 6 7 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
14/04/2014	09:47	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	NASDAQ:CADX	(MM)
01/04/2014	16:12	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(b) (15-12b)	NASDAQ:CADX	(MM)
24/03/2014	10:29	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:CADX	(MM)
21/03/2014	18:43	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CADX	(MM)
19/03/2014	15:17	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CADX	(MM)
19/03/2014	15:11	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:CADX	(MM)
19/03/2014	15:07	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:CADX	(MM)
19/03/2014	08:45	Edgar (US Regulatory)	(25-NSE)	NASDAQ:CADX	(MM)
19/03/2014	08:12	Business Wire	Mallinckrodt plc Completes $1.4 Billion Acquisition of Cadence Pharmaceuticals, Inc.	NASDAQ:CADX	(MM)
19/03/2014	05:42	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:CADX	(MM)
19/03/2014	05:23	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:CADX	(MM)
13/03/2014	17:00	Zacks	FDA Approves Mallinckrodt's Xartemis XR - Analyst Blog	NASDAQ:CADX	(MM)
13/03/2014	15:11	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:CADX	(MM)
10/03/2014	14:16	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:CADX	(MM)
06/03/2014	10:50	PR Newswire (US)	Stock Price Updates, Appointment, and Financial Results - Analyst Notes on Regeneron, DENTSPLY, AMAG, Cadence, and ArthroCare	NASDAQ:CADX	(MM)
28/02/2014	15:17	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:CADX	(MM)
28/02/2014	15:00	PR Newswire (US)	Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2013 Financial Results	NASDAQ:CADX	(MM)
19/02/2014	14:48	PR Newswire (US)	Lifshitz & Miller Law Firm Announces Investigation of Cadence Pharmaceuticals, Inc., Chindex International, Inc., LCA-Vision,...	NASDAQ:CADX	(MM)
19/02/2014	10:35	Edgar (US Regulatory)	Tender Offer Statement by Third Party (sc To-t)	NASDAQ:CADX	(MM)
19/02/2014	05:02	Edgar (US Regulatory)	Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)	NASDAQ:CADX	(MM)
17/02/2014	12:54	Business Wire	SHAREHOLDER DEADLINE: Law Office of Brodsky & Smith, LLC Announces Investigation of Cadence Pharmaceuticals, Inc. in Connecti...	NASDAQ:CADX	(MM)
14/02/2014	14:50	PR Newswire (US)	CADENCE PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout	NASDAQ:CADX	(MM)
14/02/2014	12:06	Business Wire	SHAREHOLDER DEADLINE: Law Office of Brodsky & Smith, LLC Announces Investigation of Cadence Pharmaceuticals, Inc.	NASDAQ:CADX	(MM)
14/02/2014	10:30	Edgar (US Regulatory)	Written Communication Relating to an Issuer or Third Party (sc To-c)	NASDAQ:CADX	(MM)
14/02/2014	08:21	Edgar (US Regulatory)	Schedule 13g	NASDAQ:CADX	(MM)
13/02/2014	16:33	Business Wire	INVESTOR ALERT: LEVI & KORSINSKY, LLP Announces Investigation of CADENCE PHARMACEUTICALS INC. & Its Board of Directors in Con...	NASDAQ:CADX	(MM)
13/02/2014	14:24	Business Wire	CADENCE INVESTOR ALERT: Faruqi & Faruqi, LLP is Investigating Cadence Pharmaceuticals, Inc. (CADX) in Relation to the Propose...	NASDAQ:CADX	(MM)
12/02/2014	15:07	PR Newswire (US)	SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of Cadence Pharmaceuticals, Inc. - CADX	NASDAQ:CADX	(MM)
12/02/2014	10:26	Business Wire	Cadence Pharmaceuticals Shareholder Alert: Former SEC Attorney Willie Briscoe & Powers Taylor LLP Investigate Sale to Mallinc...	NASDAQ:CADX	(MM)
12/02/2014	09:31	PR Newswire (US)	Ryan & Maniskas, LLP Announces Investigation of Cadence Pharmaceuticals Inc.	NASDAQ:CADX	(MM)

Showing the most relevant articles for your search:NASDAQ:CADX

1 2 3 4 5 6 7 Próxima >

BNP Paribas (QX)

Invesco QQQ Trust Series 1

Verizon Communications

JP Morgan Chase

US Dollar vs MXN

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones